Objective: Prolonged sitting is increasingly recognized as a ubiquitous cardiometabolic risk factor, possibly distinct from lack of physical exercise. We examined whether interrupting prolonged sitting with brief bouts of light-intensity activity reduced blood pressure (BP) and plasma noradrenaline in type 2 diabetes (T2D).
Conclusion: Interrupting prolonged sitting with brief bouts of LW or SRA reduces resting BP and plasma noradrenaline in adults with T2D, with SRA being more effective.
INTRODUCTION
Hypertension and type 2 diabetes (T2D) are common comorbidities that substantially increase the risk of both micro-and macro-vascular complications [1, 2] . Indeed, when hypertension coexists with diabetes, the risk of cardiovascular disease is increased by some 75%, which further contributes to the overall morbidity and mortality of an already high-risk population [2] . As a frontline therapy and adjunct to pharmacotherapy, lifestyle interventions -including diet and exercise (30-60 min of continuous or accumulated exercise/day and resistance exercises at least 2-3 days/week) -remain cornerstones for improving blood pressure (BP), glucose and lipid control [3] . However, despite the known benefits, many with T2D remain physically inactive [4] and spend large amounts of time in sedentary behaviors (sitting) -defined as any sitting or reclining behavior during waking hours with low energy expenditure [(<1.5 Metabolic Equivalents [5, 6] ].
Sedentary behaviors (e.g. TV viewing, other screen time, driving) have been associated with higher resting BP [7] and the onset of hypertension [8, 9] independent of moderatevigorous physical activity, adiposity, age and other common risk factors. This is consistent with experimental studies demonstrating an elevation of BP across a 3-5 hour period of sitting, with concomitant increases in leg blood pooling and total peripheral resistance, as well as reductions in thigh blood flow and endothelial function [10, 11] . In turn, there is observational and experimental evidence that regularly interrupting prolonged periods of sitting can be associated with a more favourable cardiometabolic risk profile compared to an equivalent amount of sitting time accumulated in longer, uninterrupted bouts [12] [13] [14] [15] [16] . Indeed, we recently showed that interrupting sitting time with brief intermittent walking bouts improves glycemic control in adults with T2D [15] , and reduces resting BP in overweight/obese adults [17] . Whether the resting BP benefits extend to those with established cardiometabolic disease, such as T2D, remains unknown. Furthermore, no study has examined the utility of interrupting sitting via brief bouts of simple resistance-type activities performed in a fixed position, an approach which may provide a potent metabolic or cardiovascular stimulus, and offer a pragmatic alternative during work tasks or leisure-pursuits where sitting time is frequently accrued.
Accordingly, we examined the effects of interrupting sitting time with brief bouts of light-intensity walking (LW) or simple resistance activities (SRA) on resting BP in adults with T2D. Given the known effects of exercise on BP and the sympathetic nervous system [18] [19] [20] , concurrent changes in plasma noradrenaline (NA) were assessed to inform about this as a potential candidate mechanism. We hypothesized that resting BP and NA levels during prolonged sitting would be attenuated by brief (3 min) intermittent bouts of light-intensity physical activity. 
METHODS

Participants
Study design
This randomized crossover trial was undertaken at the Baker IDI Heart & Diabetes
Institute between October 2013 and November 2014. Detailed screening and testing procedures have been described previously [15] . In brief, participants attended the laboratory on five separate occasions: 1) medical screening visit; 2) familiarization visit; and 3-5) three acute trial condition visits in a randomized order, each separated by 6-14 days. Trial condition order was randomized by a third party (block-randomization and balanced block sizes) and stratified by gender. Power calculations were based on the coprimary outcomes (postprandial glucose and insulin responses following mixed meals) [15] , with blood pressure a pre-specified secondary endpoint of the study. Participants underwent initial orientation to SRA and LW activities during screening and familiarization to ensure the activity interventions could be undertaken safely and consistently.
Experimental protocol
On trial condition days, participants arrived at the laboratory at 0715 h after a 12 h fast, having abstained from caffeine, alcohol, and structured moderate-vigorous physical activities (i.e., no physical activity beyond activities of daily living) for 48 h. Each trial condition (see Figure 1 ) commenced with a 60 min 'steady-state' period (-1 h to 0 h), after which participants consumed standardized breakfast (0 h) and lunch (3.5 h) meals, with the time taken to consume (<20 min per meal) replicated in subsequent conditions.
An indwelling catheter was inserted into an antecubital vein at -1 h and a fasting INSERT FIGURE 1 ABOUT HERE Meals were standardized between conditions and were individualized to each meet 33% of daily estimated energy requirements [21] (mean±SEM, 823±25 kcal/meal). The target macronutrient profile was 12-15% energy from protein, 55-58% from carbohydrate and 29-31% from fat. An evening meal pack was also provided for participants to prepare at home on the evenings prior to experimental conditions.
Participants sat upright in a comfortable chair throughout all experimental conditions and were instructed to minimize excessive movement, only rising from the chair to void.
Standardized lavatory visits incorporated into the protocol minimized unscheduled physical activity; however, additional lavatory visits were permitted. Participants complied with the respective trial condition protocols under direct supervision from research staff. They had access to television, DVDs, books, magazines and internet services during the trial conditions. Participants completed each experimental trial condition in a private clinic room. They were permitted to check emails, but were asked to avoid potentially stimulating activities that may influence their BP, such as horror/suspense movies, computer gaming and/or gambling. Activity intensity during the trial conditions was monitored using heart rate (difference pre-versus post activity-bout) and the Borg Rate of Perceived Exertion (RPE; 6-20) scale. As previously reported, the difference for heart rate [immediately post-activity bout minus pre; mean±SEM (range: min-max)] for the LW and SRA activity-break conditions were 17±1.2 (8-31) and 19±1.0 (10-30) bpm, and for mean RPE was 9±0.3 (7-12) and 10±0.3 (7-13) points, respectively.
Blood pressure measurement and biochemical analysis
Resting BP and heart rate were measured in the seated upright position using an automated oscillometric blood pressure monitor (Digital Automatic Blood Pressure
Monitor HEM-907, Omron, Kyoto, Japan). All measures were taken by trained research personnel, using an appropriately sized cuff. The same protocol for BP recordings applied at the initial screening/informed consent visit (i.e. average of three consecutive measures taken 1 min apart) was followed at each time point of each experimental condition (see Figure 1 for specific time points). The sequence of 3 measurements was always initiated 10 min before activity bouts. Measurements were taken on the same arm for all conditions, contralateral to the arm with the indwelling venous catheter (excepting 6 participants, for whom the alternate arm was used due to difficulties with the cannulation procedure).
Blood samples for plasma catecholamine determination were drawn into EGTAglutathione tubes, centrifuged within 5 min of collection (2000 rpm for 15 min at 4°C), and the plasma stored at -80°C. Plasma NA concentrations were determined by highperformance liquid chromatography with coulometric detection, following extraction from plasma using alumina adsorption [22] . Recoveries of internal standard were used to adjust for loss during extraction. Intra-assay and inter-assay coefficients of variation were 1.3% and 3.8%, respectively. Assays for each individuals' three visits were completed in one assay run.
Statistical analyses
Generalized linear mixed models with random intercepts were used to evaluate the differential effects of the experimental conditions on the selected outcomes using Stata Post-hoc analyses were also performed for each outcome to explore the potential influence of antihypertensive medications and baseline BP values.
RESULTS
Participant characteristics
Twenty-four participants [ n=23 taking metformin; n=15 taking statins] were randomized and completed all trial conditions. They were predominantly pre-or hypertensive (88%), with n=3 (12%) normotensive, n=4 (17%) pre-hypertensive, and n=17 (71%) hypertensive [23] .
Participant attributes were comparable between genders for age, waist circumference and baseline BP/metabolic data, however BMI was significantly higher for women Conversely, within-condition changes for LW and SRA indicated progressive reductions in systolic (-10±1 and -12±2 mmHg) and diastolic (-6±1 and -8±1 mmHg) BP by the end of the day (both P<0.001).
INSERT FIGURE 2 ABOUT HERE
Gender, antihypertensive medications and baseline BP
A significant gender-by-condition interaction effect was observed for the mean difference in systolic BP between conditions SIT and SRA (Supplemental Figure S1 );
indicating that, while still significantly lower for both genders, the magnitude of the systolic BP reduction for SRA versus SIT was greater (↓15% versus ↓11%) in women than in men. Reductions in all BP and heart rate variables were not influenced by antihypertensive medications, however, the magnitude of the mean NA reduction was significantly greater (↓6% versus ↓22%) for SRA compared to SIT in those taking antihypertensive medications (Supplemental Figure S1 ). Treatment with specific medications known to increase NA reflexively (i.e. diuretics and/or calcium channel blockers) was not associated with differential BP or plasma NA effects (i.e. vs. treatment with other antihypertensives and vs. no antihypertensive treatment. The magnitude of the difference in mean systolic BP with interrupted sitting tended to be greater in those participants with higher baseline systolic BP compared to those with lower baseline systolic BP; however, only the SRA-by-baseline systolic BP interaction was statistically significant (P=0.046 for SRA, P=0.076 for LW; Supplemental Figure S2 ). No significant interactions were observed for any other outcomes (non-significant data not reported).
DISCUSSION
The major novel finding of this study is that, in overweight/obese inactive men and women with T2D, interrupting prolonged sitting with brief intermittent bouts of either light-walking or simple resistance activities acutely reduced resting systolic and diastolic BP. This BP differential reflected both a progressive elevation in BP from baseline in the prolonged sitting condition and a progressive reduction in BP during the activity bout conditions. The BP-lowering effects on both activity days were paralleled by a significant reduction in plasma NA levels, although changes in systolic and diastolic BP and NA
were not significantly correlated. Moreover, the magnitude of reductions in BP and NA were significantly greater with the simple resistance activities compared to the light walking. The present results extend recent findings in overweight/obese adults [17] by demonstrating the potential hypotensive effects of interrupting prolonged sitting in patients with T2D -which, if sustained, are comparable to that of monotherapy with many common anti-hypertensive drugs [24] .
Evidence on the duration and intensity required for optimal BP reduction with accumulated activity bouts is limited, and less is known about the antihypertensive effects of even shorter (<10 min) bouts of light-intensity physical activity. Miyashita and colleagues showed that accumulating 30 min of brisk walking [25] or running [26] in 3 min bouts interspersed throughout the day was as effective as a 30 min continuous bout of similar intensity in reducing acute and second day systolic BP in young normotensive/pre-hypertensive men. Interestingly, the BP reduction observed for the intermittent running bout condition was no greater than walking bouts, despite increases in intensity and energy expended, which was similar to findings in sedentary adults [27] .
It was also recently reported in overweight/obese adults that accumulating 2.5 h of standing or light-intensity physical activity during an 8-h workday equally improved ambulatory BP during and after work hours, compared to prolonged sitting [28] . These data and ours are congruent with previous literature regarding a light-intensity physical activity 'threshold' for blood pressure lowering [3, 29] , which may even be related to simple postural change. It is possible that the increased intensity and/or compound nature of the skeletal muscle contractile activity associated with the simple resistance activities evoked a stronger muscle pressor reflex, with greater post-activity vasodilatation in the absence of a compensatory increase in cardiac output, potentially contributing to lower NA and BP [30, 31] . These factors, along with the optimal mode, frequency, duration and intensity of very short activity bouts for blood pressure control in T2D and hypertensive patients, should be examined in future studies.
Consistent with previous evidence on the influence of continuous exercise on BPlowering [3] , participants with higher baseline systolic BP generally showed a more pronounced reduction in systolic BP during the physical activity conditions, relative to prolonged sitting. The increased magnitude of BP reduction during the simple resistance activity condition for women compared to men, while intriguing and consistent with epidemiological findings that have documented gender differences in the associations of television viewing time with cardiometabolic risk biomarkers [32, 33] , is challenging to explain. We did not observe significant changes in heart rate, oxygen consumption, perceived exertion or plasma NA levels (stratified data not reported) for women compared to men, which may have formed a plausible basis for these gender variations.
It should also be noted that all women were post-menopausal (although not significantly older than the men) and were not taking hormone replacement therapy. Differences in adipose and lean body mass or other biological disparities between men and women with T2D could be the potential basis for gender differences.
The mechanisms accounting for the reported blood pressure reductions with interrupted versus uninterrupted sitting are likely to be multiple [3, 34] . Lower sympathetic nerve activity is the most salient feature of post-exercise hypotension [18, 19] which may contribute to reductions in both cardiac output and total peripheral resistance. A role for this mechanism is supported by our observation of reduced plasma NA levels during the activity bout conditions, although more direct indices of sympathetic nervous system activity would be required for definitive proof. Interestingly, any reductions in sympathetic nervous system activity may either be a direct consequence of the interrupted sitting intervention, or secondary to reductions in plasma insulin [15, 35, 36] .
Further, evidence suggests that interruptions in sitting time may promote endothelialdependent vasodilation via increased arterial shear stress secondary to activity-related blood flow and heart rate elevation [37, 38] . Although direct measurements of blood flow, cardiac output and/or sympathetic activity would have compromised the present study design, such measures, or more sophisticated tracer techniques to address whether neurotransmitter levels were a result of decreased clearance or increased release, would be highly informative in future studies.
Strengths of this study include: the well-controlled randomized cross-over study design, allowing for within and between participant comparisons and a smaller sample size; the standardized trial condition lead-in periods, with strict but pragmatic control of confounder variables such as diet, physical activity, and fasting metabolic levels; hourly blood pressure assessment using automated serial measurements; and, full retention of participants. The potential efficacy of an alternative, simple and practical form of sitting interruption (brief bouts of simple resistance activities) was also demonstrated, suggesting that the benefits associated with sitting interruptions may not be limited to only those involving ambulatory activities. Given the acute nature of this trial, we can only speculate on possible longer term exposures. It is also possible that the BP reductions observed in this study may be smaller if the sitting (control) condition was more reflective of free-living conditions. As such, assessment of ambulatory blood pressure over consecutive days under free-living scenarios would be an important next step. Finally, further research is needed to determine whether effects can be generalized to other populations -including the non-obese, pre-menopausal women, and less wellcontrolled T2D patients (i.e. insulin-dependent with beta cell dysfunction) -who may have differing levels of sympathetic activation; and, identify whether the approach we have tested is feasible and beneficial for those limited physically by diabetic complications or by other co-morbidities.
We have shown that interrupting prolonged sitting with brief light walking or simple resistance activity bouts acutely reduces resting BP and plasma NA levels in adults with T2D, most of whom were also hypertensive. Thus, interrupting prolonged sitting may be a practical strategy that could contribute towards minimizing the risk of micro-and Data are mean±SD or number (%). SSRI, Selective serotonin reuptake inhibitor; SNRI, Serotonin and norepinephrine reuptake inhibitor; ACE, Angiotensin converting enzyme; ARB, Angiotensin II receptor blocker. Note: blood pressure measurements were collected during the screening visit. Fasting metabolic measurements were collected at the beginning of the first trial condition.
